ARQT: Arcutis Biotherapeutics Inc

14.88 USD 0.21 (1.39%)

Secteur: Soins de Santé Base: US Dollar Devise de profit: US Dollar

Le taux de change de ARQT a changé de -1.39% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 14.82 et à un maximum de 15.37.

Suivez la dynamique Arcutis Biotherapeutics Inc. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.

Graphique en Plein Ecran

ARQT Nouvelles

Zacks 14:00 Arcutis Biotherapeutics, Inc. (ARQT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Benzinga 12:34 This Palantir Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Applied Optoelectronics (NASDAQ:AAOI), Arcutis Biotherapeutics (NASDAQ:ARQT)
Investing 11:56 Guggenheim maintains Buy rating on Arcutis Biotherapeutics stock amid prescription growth
Investor's Business Daily 22:55 Netflix Among 9 Stocks Elevated To IBD Best Growth Stock Lists: Who's On The IBD 50, Other Premium Lists?
Investor's Business Daily 16:25 Arcutis Stock Awaits Next Move In A Base; Its Skin Drug Sales Grew 196%
Investing 20:04 Arcutis Bio EVP Burnett sells $432k in ARQT stock after option exercise
Investor's Business Daily 23:02 Western Digital In 9-Week Win Streak, On 2 Top Stock Watchlists: Check Out IBD 50, Stock Spotlight, Others
Investor's Business Daily 07:00 Arcutis Biotherapeutics Stock Scores RS Rating Upgrade
Investing 14:17 Morgan Stanley assumes coverage of Arcutis Biotherapeutics stock with Overweight rating
Seeking Alpha 03:25 Arcutis Biotherapeutics: A Closer Look At The Atopic Dermatitis Direction (NASDAQ:ARQT)
Investing 12:59 Arcutis’ ZORYVE ® (roflumilast) Cream 0.15% Receives Strong Recommendation in American Academy of Dermatology Updated Guidelines for Adult Atopic Dermatitis
Seeking Alpha 02:40 AMG GW&K Small Cap Core Fund Q1 2025 Commentary
Seeking Alpha 08:43 Arcutis Biotherapeutics Stock: Another Approval Under Their Belt (NASDAQ:ARQT)
Seeking Alpha 03:57 Arcutis Stock: Out Of The Woods, Ready For Commercialization. (NASDAQ:ARQT)
Seeking Alpha 14:10 PGIM Jennison Health Sciences Fund Q1 2025 Commentary (PHLAX)
Investing 14:00 Arcutis Enrolls First Child in INTEGUMENT-INFANT Evaluating ZORYVE ® (roflumilast) Cream 0.05% in Infants with Atopic Dermatitis
Investing 11:27 H.C. Wainwright maintains $19 target on Arcutis stock
Investing 20:20 Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Benzinga 15:11 Arcutis Unveils Long-Term Efficacy, Safety For Zoryve Cream In Pediatric Patients With Atopic Dermatitis - Arcutis Biotherapeutics (NASDAQ:ARQT)
Investing 12:12 Arcutis to Present New Long-Term Results of ZORYVE ® (roflumilast) Cream at the 2025 Revolutionizing Atopic Dermatitis Conference
Seeking Alpha 05:07 Arcutis Stock: Navigating Commercialization With Promising Upside (NASDAQ:ARQT)
Investing 11:46 H.C. Wainwright reiterates buy rating and $19 target on Arcutis stock
Investing 00:31 Arcutis Biotherapeutics SVP sells $24,806 in stock
Investing 21:08 Arcutis to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

Range quotidien

14.82 15.37

Range Annuel

7.86 17.74

Clôture Précédente: 14.99
Ouverture: 15.09

Bid: 14.88
Ask: 15.18

Plus Bas: 14.82
Plus Haut: 15.37

Volume: 1.238 K

Changement quotidien: -1.39%
Changement Mensuel: 7.13%

Changement à 6 Mois: 15.44%
Changement Annuel: 46.89%

30 juillet, mercredi